TL;DR
EMTT and shockwave therapy (ESWT) are both non-invasive, drug-free technologies, but they work through different mechanisms and have different evidence bases depending on the condition. More on its role is in EMTT therapy for pain relief in Brooklyn.
- Shockwave therapy uses acoustic pressure waves; EMTT uses a pulsed electromagnetic field.
- EMTT is not the same as PEMF. It operates at a higher energy level than standard PEMF devices.
- Shockwave has a larger body of research behind it, particularly for tendon conditions.
- EMTT’s evidence base is smaller and still developing, and it is considered individually by a clinician as part of a broader plan.
If you’ve been offered shockwave therapy, EMTT, or both, it’s reasonable to wonder what actually separates them. Here is how the two technologies differ, and how a provider decides which one, if either, fits your situation.
What is the basic difference between EMTT and shockwave therapy?
Shockwave therapy, or Extracorporeal Shock Wave Therapy (ESWT), delivers acoustic pressure waves through the skin to the target tissue, which is thought to stimulate a local biological response involved in tissue repair and pain modulation. EMTT, Extracorporeal Magnetotransduction Therapy, works differently: it uses a pulsed, high-energy electromagnetic field rather than a mechanical pressure wave. Both are applied externally, without needles or incisions, but the underlying physics and proposed mechanism are not the same.
Is EMTT the same thing as PEMF?
No. EMTT and PEMF (pulsed electromagnetic field therapy) are related in that both use electromagnetic fields, but EMTT operates at a substantially higher energy level than standard PEMF devices. Treating them as interchangeable is inaccurate, and it can create confusion about what the evidence for each actually supports. If you see the term PEMF used to describe EMTT, that is not correct. The technology itself is explained in electromagnetic transduction therapy in Brooklyn.
What does the research actually show for each?
Shockwave therapy has the larger evidence base of the two, with a substantial body of research, particularly for tendon-related conditions like tennis elbow and plantar fasciitis, and a growing set of studies in areas like chronic low back pain and myofascial pain. EMTT’s evidence base is smaller and newer. A 2025 randomized, placebo-controlled trial studied EMTT for knee osteoarthritis, rotator-cuff enthesopathy, and lumbar spondyloarthrosis, but this single trial does not establish efficacy across every condition it might be offered for. Neither technology should be assumed to work the same way for every diagnosis; the evidence is specific to the condition being studied.
Does one work better than the other?
There is no general answer to that. The right technology, if either applies at all, depends on your specific diagnosis, what the evidence actually supports for that condition, and how you’ve responded to treatment so far. For some conditions, like chronic tennis elbow, there is meaningful comparative research against other treatments. For many other conditions, the honest answer is that the evidence for one or both technologies is still limited, and they are considered as a possible adjunct within a broader plan, not a guaranteed fix.
What does treatment with either technology actually feel like?
Both are applied externally over the affected area during an office visit, without needles, incisions, or downtime. Sensations vary by patient and by device settings, and your provider will explain what to expect for your specific treatment before starting. Neither is a substitute for a full evaluation; they are tools that may be incorporated once your diagnosis and treatment plan are established.
How does a provider decide which technology to use?
Your provider bases this on your specific diagnosis, the evidence available for that condition, and your treatment history, not a default choice applied to every patient. Some patients are not candidates for either technology, and for those patients, physical therapy, activity modification, or other options may be more appropriate as a starting point.
Are there safety considerations specific to either technology?
Yes. Because EMTT uses an electromagnetic field, it is generally not used on patients with pacemakers or other implanted electronic devices, and it is avoided during pregnancy. Shockwave therapy is generally avoided over areas with active infection, in patients on certain blood-thinning medications, over open growth plates in children, and during pregnancy. Neither is appropriate for every patient, which is another reason both start with a full evaluation rather than a standing offer to anyone who asks.
Frequently asked questions
Can I request EMTT or shockwave therapy specifically?
Your provider will let you know whether either technology is appropriate for your specific diagnosis based on your evaluation, rather than treatment being chosen by patient request alone.
Are EMTT and shockwave therapy covered by insurance?
Coverage varies by plan and by the specific diagnosis being treated. Checking benefits before starting a course of treatment is the way to know where you stand.
Do these treatments hurt?
Sensations vary by patient and by device settings. Your provider will explain what to expect before your specific treatment begins.
How many sessions are typically needed?
This varies by condition and by how you respond to initial treatment. Your provider can give you a more specific expectation once your plan is established.
Is either treatment a cure?
No. Both are considered possible adjuncts within a broader treatment plan, not guaranteed or standalone cures for any condition.
Take the next step
The right technology, if any, depends on the specific diagnosis. An evaluation that identifies the tissue involved is what determines whether either device fits.
Ready to get real relief?
We verify your coverage before your visit and build a non-surgical plan that fits you.
Serving Brooklyn, the Five Towns, and Monsey.
Sources: Extracorporeal shock wave therapy mechanisms in musculoskeletal regenerative medicine; Huber et al., Extracorporeal Magnetotransduction Therapy for Management of Musculoskeletal Disorders, International Journal of Rehabilitation Research, 2025.
